EL
The startup has developed an automated in silico platform that accurately predicts enzyme activity across various sequences, structures, and catalytic characteristics. This technology enables chemical industries to efficiently screen thousands of enzyme mutants, significantly accelerating the identification of the most active enzymes.
Updated 3 months ago
Funding
$2.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup has developed an automated in silico platform that accurately predicts enzyme activity across various sequences, structures, and catalytic characteristics. This technology enables chemical industries to efficiently screen thousands of enzyme mutants, significantly accelerating the identification of the most active enzymes.